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Health Economics. 2019;1–6.Abstract
The spread of fake news and misinformation on social media is blamed as a pri-
mary cause of vaccine hesitancy, which is one of the major threats to global
health, according to theWorld Health Organization. This paper studies the effect
of the diffusion of misinformation on immunization rates in Italy by exploiting a
quasi‐experiment that occurred in 2012, when the Court of Rimini officially
recognized a causal link between the measles‐mumps‐rubella vaccine and
autism and awarded injury compensation. To this end, we exploit the virality
of misinformation following the 2012 Italian court's ruling, along with the inten-
sity of exposure to nontraditional media driven by regional infrastructural di-
fferences in Internet broadband coverage. Using a Difference‐in‐Differences
regression on regional panel data, we show that the spread of this news resulted
in a decrease in child immunization rates for all types of vaccines.
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JEL CLASSIFICATION
I12; I18; L82; L861 | INTRODUCTION
Several countries are experiencing outbreaks of vaccine‐preventable diseases, such as measles and diphtheria. For exam-
ple, in 2018, measles cases increased by 30% globally (World Health Organization, 2019). On 29 January 2019, Washing-
ton State officially declared a state of emergency due to a measles epidemic. In Europe, between 1 February 2017, and 31
January 2018, the European Surveillance System reported 14,732 cases of measles. Among European countries, Italy
(4,978 cases) had the highest incidence, just after Romania (5,224 cases; European Centre for Disease Prevention and
Control, 2019). These worrying statistics led the World Health Organization to include Vaccine hesitancy—that is,
the reluctance or refusal to vaccinate despite the availability of vaccines—as one of top 10 threats to global health today.
The spread of fake news and misinformation on social media is blamed as a primary cause of vaccine hesitancy
(Aquino et al., 2017; Dube, Vivion, & MacDonald, 2015; Jolley & Douglas, 2014; Smith & Marshall, 2010). This origi-
nated from the measles‐mumps‐rubella (MMR)—autism controversy that stemmed from Andrew Wakefield's fake
study. A number of papers found that this controversy had a significant effect on immunization choices. Anderberg,- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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2 CARRIERI ET AL.Chevalier, and Wadsworth (2011) found an effect on the uptake of the MMR vaccine in the United Kingdom, which
dropped by over 5% points in 5 years, before rising again. Similarly, Smith, Ellenberg, Bell, and Rubin (2008) examined
MMR uptake and nonreceipt in the United States and found declines in 1999 and 2000 and then a return to previous
levels of vaccination. More recently, Chang (2018) showed that controversy led to a decline in MMR immunization rates
and negative spillovers onto the use of other vaccines in the United States.
This paper complements these existing studies in two important ways. First, it exploits a quasi‐experiment that
occurred in March 2012 in Italy, when the Court of Rimini granted compensation to a family after recognizing that
the MMR vaccine caused their child's autism. To our knowledge, this was the first time that an official body formally
recognized a causal link between the MMR vaccine and autism. The decision was initially covered by the most read
national media outlets (e.g., La Repubblica and Il Corriere della Sera). However, following the court's decision, people's
concerns about vaccine side effects were proliferated on the Internet. Misinformation and fake news surrounding
vaccines, now supported by a judge, went viral. Figure 1 shows that the number of queries for “vaccines and autism”
on the search engine Google increased drastically after March 2012 and remained quite stable afterwards. Compared
with pre‐2012, the volume of searches increased by 600%. Indeed, as also supported by the relevant medical literature
such as Aquino et al. (2017) and Donzelli et al. (2018), the court's ruling allows us to establish a crucial trigger for
the virality of (fake) news and misinformation surrounding vaccines in Italy.
Second, as access to nontraditional media and exposure to misinformation is facilitated by Internet availability, we
exploit the heterogeneity in regional (NUTS‐2 level) broadband coverage across areas of the country. Broadband cover-
age depends on the local historical infrastructural system, which has undergone several structural changes in the period
we considered, to bridge the long‐lasting “Digital Divide” in Italy. In the period analyzed, broadband coverage in Italy
passed from 15% in 2006 to 76% in 2016. This was essentially due to the “Digital Italy” plan launched by the Italian Gov-
ernment in 2008 to reach the ambitious goals of “Europe 2020,” the strategy of the European Union to ensure full
broadband access (up to 30 Mbps) for all Europeans by 2013 and 50% ultra‐broadband coverage (up to 100 Mbps) by
2020. Basically, all territorial areas were supposed to reach these goals and, with different intensities and timings, were
exposed to broadband deployment and upgrade. In practice, the rate of change in broadband coverage was dependent
on the historical condition of the telephone line network. This is because the broadband network basically exploits the
regular copper phone lines once adapted with xDSL technologies (Infratel, 2011). Further, the complex orography of the
territory makes the adaptation of the phone lines even more difficult in some areas, and this represents a further source
of heterogeneity in broadband coverage across the Italian territory. As a result, the changes in broadband coverage are
thus unlikely to be correlated with the demand for high‐speed Internet, and this provides an exogenous variation in the
regional exposure to news. Similar identification strategies using discontinuities in broadband coverage have been
widely used to estimate the effect of the Internet and media exposure on other relevant outcomes (see, e.g., Falck, Gold,
& Heblich, 2014; Gavazza, Nardotto, & Valletti, 2018).
We combine both sources of variations (i.e., the 2012 court ruling and heterogeneity in broadband coverage) in a
Difference‐in‐Differences (DiD) framework. We find that the spread of misinformation surrounding vaccines following
the court's ruling caused a significant reduction in child immunization rates.FIGURE 1 Google trends for “vaccini autismo” (vaccines autism) in Italy, 2006–2018. Own elaboration on Google Trends data [Colour
figure can be viewed at wileyonlinelibrary.com]
CARRIERI ET AL. 32 | METHODS AND DATA
We use a unique longitudinal dataset recording regional data on child immunization rates in Italy, matched with
information on broadband coverage from 2006 to 2016 for all 21 NUTS‐2 areas (19 regions and two autonomous prov-
inces).1 This leads to a total sample of approximately 215 nonmissing observations. Data on regional broadband cover-
age are made available by the EUROSTAT; regional data on vaccines are provided by the Italian Ministry of Health.
These include the percentage of the targeted population for all childhood vaccines (i.e., from 0 to 24 months). During
the period considered, that is, 2006–2016, vaccines such as MMR, diphtheria‐pertussis‐tetanus (DTP), Polio (POL),
and Hepatitis B (EpB) were mandatory by law, whereas Haemophilus influenzae type B (HIB) was highly recommended.
These refer to coverage at 24 months for complete cycles of three doses of all vaccines but MMR, which is instead deliv-
ered in one dose.
We set up a DiD model as follows:
Yrt ¼ β1Post þ β2BBcoverager;t þ β12Post × BBcoverager;t þ δXit þ μr þ λt þ εrt; (1)
where Yrt is the yearly regional immunization percentage rate for all types of child vaccines: MMR, DTP, HIB, POL, and
EpB. Post is the indicator of the post‐2012 court decision period; whereas BBcoverage is our treatment intensity variable
and measures the percentage of households that are connectable to broadband fixed and/or mobile connections.2 Xit is a
vector of controls accounting for the socioeconomic development of the area, such as regional per‐capita disposable
income and the share of university graduated individuals in the region. μr accounts for time‐invariant differences
between regions; whereas, in order to preserve the parsimony due to the small sample size, time effects are taken into
account through the inclusion of a linear trend in our model (λt). Finally, εrt is the idiosyncratic error term.
To assess the robustness of our findings, we estimate two additional versions of Equation (1). First, we augment our
DiD regression by adding linear region‐specific time trends. Second, in order to assess to what extent our estimates are
affected by trends in regional socioeconomic development, we also estimate Equation (1) without the inclusion of socio-
economic controls (Xit.) Lastly, following Bertrand, Duflo, and Mullainathan (2004), we perform randomization tests by
estimating Equation (1) using a random selection of a set of different time periods and treatment intensities
(Year × BBcoverage) and using these placebo treatments rather than the real one. We then perform a Monte Carlo sim-
ulation of these estimates with 2,000 repetitions in order to build a distribution of placebo treatment effects. This allows
us to assess the credibility of the identification strategy and to check the robustness of our results to different assump-
tions about the structure of the error distribution.3 | RESULTS
In column 1 of Table 1, we report the DiD estimates of Equation (1) for all vaccines separately and for an overall mea-
sure of average immunization rates. We find a negative average treatment effect on all vaccines considered. Specifically,
we find that a 10 percentage points increase in local broadband coverage led to a significant reduction of 1.23 percentage
points in POL coverage, 1.14 in DTP coverage, 1.55 in EpB coverage, and 1.44 MMR coverage. To retrieve the relative
size of the effect, we also present the percentage change with respect to the average immunization rates of each vaccine.
This shows a similar reduction across the different vaccines (1.2–1.6%), with the highest effect found for the MMR and
EpB. For the case of HIB, the spread of misinformation entailed a negative effect, although not statistically significant.
In the period we considered, the HIB vaccine was only highly recommended, whereas all the others were compulsory.1In Italy, immunization programs are managed in the context of the National Health Service, which provides universal health coverage by setting the
core benefits package of health services to be guaranteed to all citizens and fund them through the National Health Fund. In the field of immuniza-
tion, the Ministry of Health, in agreement with the State‐Region Conference, issues the Italian National Immunization Prevention Plan (Piano
Nazionale di Prevenzione Vaccinale). This includes a set of vaccinations that are mandatory by law for all newborns. Mandatory childhood vaccina-
tions are guaranteed free of charge for all Italians as well as foreign children who live in the country, and they are delivered in different doses up to
24 months of age. Regional health authorities can only set formal agreements about the offer of immunization not covered by the law, that is, they can
increase the set of vaccinations offered. The access to the mandatory vaccines is thus uniform over the entire territory by law.
2Following the EUROSTAT definition, broadband coverage at the local level is measured as “the percentage of households (with at least one member
aged 16 to 74) that are connectable to an exchange that has been converted to support xDSL‐technology, to a cable network upgraded for internet traf-
fic, or to other broadband technologies.” Note that this indicator refers to the connectable households and not to the households having a broadband
subscription.
TABLE 1 Difference‐in‐Differences regression
Baseline Robustness checks
(1) (2) (3)
Outcome DiD S.E. % DiD S.E. DiD S.E.
POL −0.123** 0.044 −1.3% −0.101*** 0.034 −0.129*** 0.039
DTP −0.114** 0.043 −1.2% −0.101*** 0.032 −0.119*** 0.040
EpB −0.155*** 0.043 −1.6% −0.131*** 0.038 −0.161*** 0.039
HIB −0.073 0.054 −0.8% −0.038 0.088 −0.076 0.057
MMR −0.144** 0.055 −1.6% −0.193*** 0.058 −0.156*** 0.052
ALL −0.122*** 0.038 −1.3% −0.113*** 0.038 −0.128*** 0.036
Note. DiD coefficients of Fixed Effects estimates of Equation (1) according to several specifications. Column (1) represents the estimation of Equation (1). Col-
umn (2) includes a region‐specific time trend, whereas column (3) includes no control. Percentage change are calculated w.r.t. the average outcome rate in
response to a 10% variation in the treatment intensity variable. Outcome variables defined as follows: vaccine coverage at 24 months for complete cycles (three
doses) of Polio (POL), diphtheria‐pertussis‐tetanus (DTP), Haemophilus influenzae type B (HIB), Hepatitis B (EpB), and one dose of measles‐mumps‐rubella
(MMR). ALL includes average immunization rates. Standard errors clustered at regional level in italics.
***Statistically significant at 1%.
**Statistically significant at 5%.
*Statistically significant at 10%.
4 CARRIERI ET AL.As misinformation was mainly surrounding compulsory vaccines, this could be a plausible explanation for the absence
of a significant effect for this vaccine.
The magnitude of our results raises important public health implications. In fact, this reduction led immunization
rates to reach below 95%, which is considered the herd immunization threshold. These results are also robust in mag-
nitude to alternative specifications, that is, when augmenting Equation (1) by including region‐specific trends (column
2) and when excluding regional socioeconomic controls (column 3).FIGURE 2 Trends in immunization rates across regions below and above the median of the treatment intensity variable. Note. The figure
shows the precourt and postcourt ruling trends of immunization rates below (blue line) and above (red line) the time‐varying median of the
regional broadband coverage. Outcome variables defined as follows: vaccine coverage at 24 months for complete cycles (three doses) of Polio
(POL), diphtheria‐pertussis‐tetanus (DTP), Haemophilus influenzae type B (HIB), Hepatitis B (EpB), and one dose of measles‐mumps‐rubella
(MMR). ALL includes average immunization rates. After the Court's decisions, the reduction in immunization rates was more marked for
regions with a larger broadband coverage (red line) [Colour figure can be viewed at wileyonlinelibrary.com]
FIGURE 3 Placebo estimates. Kernel density distribution of 2000 placebo estimates for all types of vaccines [Colour figure can be viewed
at wileyonlinelibrary.com]
CARRIERI ET AL. 5In Figure 2, we perform a graphical inspection of the trends of immunization rates across regions below and above the
time‐varyingmedian of the treatment intensity variable. Visual inspection suggests that the common trend hypothesis can
be credibly maintained. The figure also shows a visible drop in the immunization rates after the decision, and such a
reduction is more marked for regions with a larger broadband coverage (red line). However, to reduce any residual con-
cern about possible violations of common trend assumption, in Figure 3, we present the nonparametric distribution of
placebo estimates. As the mean of the distribution is virtually zero, the estimator is unbiased. Moreover, all the average
treatment effects we estimate in Table 1 fall in the very extreme left tail of this distribution. This increases the confidence
that the effect we estimate is not obtained by chance and provides full support for our identification strategy.4 | CONCLUSIONS
Fake news and misinformation on social media are often blamed as the cause of the reduction in immunization rates
worldwide. Recently, this has pressured policymakers, health authorities, and social media to seek regulatory interven-
tions (see, e.g., Chiou & Tucker, 2018). Our paper aimed to provide causal evidence of the effects of fake news and
misinformation on vaccine immunization rates. We exploited a quasi‐experiment that occurred in Italy when the Court
of Rimini officially recognized a causal link between the MMR vaccine and autism and awarded vaccine‐injury compen-
sation. After the decision, fake news and misinformation on vaccines went viral on the Internet. Building on growing
literature studying the effects of the Internet on real‐life outcomes, we found that after the court's ruling in 2012, larger
accessibility to nontraditional media (via broader broadband coverage) led to a reduction in child immunization rates.
Interestingly, the negative and significant effect we found encompasses all vaccines and led immunization rates to reach
below the critical threshold of 95%. Our results thus corroborate the thesis that misinformation is a dangerous cause of
the vaccine hesitancy issue.ACKNOWLEDGEMENTS
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